At last, a randomised controlled trial on antihypertensives in COVID-19

The study suggests ACE inhibitors and ARBs are safe, although a leading cardiologist suggests this is 'not the last word'

AusDoc brings you the latest news from the European Society of Cardiology Congress 2020.

Patients on common antihypertensives can continue the medication even if hospitalised with COVID-19, according to the first randomised controlled trial to address the issue.

The BRACE-CORONA trial, conducted in Brazil, found there was no mortality difference between patients who continued to take ACE inhibitors or ARBs and those who ceased the medication, the